Public Release: 

Drug improves PTSD traits in rat model of explosive blasts

Study addresses brain injury common in veterans of recent conflicts in Iraq and Afghanistan

Society for Neuroscience


IMAGE: This is experimental design and timing. view more 

Credit: Perez-Garcia et al., eNeuro (2018)

Male rats exposed to air blasts designed to mimic those from explosives used in recent military conflicts have symptoms of post-traumatic stress disorder (PTSD) that are improved by a drug currently being evaluated in humans for treatment-resistant depression and suicidal tendencies. The research, published in eNeuro, provides a new direction for addressing the mental health problems that often arise following a common brain injury in veterans.

Concussions are the most prevalent form of traumatic brain injury (TBI) among military personnel, and many cases go unreported. These injuries have been largely caused by the high pressure emanating from improvised explosive devices in Iraq and Afghanistan. PTSD and depression are increasingly diagnosed in patients with mild TBI, including some cases in which veterans do not recall a traumatic experience, suggesting that the blast itself may be responsible for these conditions.

Sam Gandy, Greg Elder and colleagues found that treating rats two weeks after being exposed to multiple high pressure blasts with a low or high dose of BCI-838 -- a drug in clinical trials that targets receptors of the neurotransmitter glutamate -- alleviated anxiety and fearful behaviors as well as memory deficits. The drug also promoted the generation of new brain cells in the hippocampus, which may be one way it exerts these effects.


Article: PTSD-related behavioral traits in a rat model of blast-induced mTBI are reversed by the mGluR2/3 receptor antagonist BCI-838

Corresponding authors:

Sam Gandy
Greg Elder
Icahn School of Medicine at Mount Sinai
New York, NY, USA

About eNeuro

eNeuro, the Society for Neuroscience's new open-access journal launched in 2014, publishes rigorous neuroscience research with double-blind peer review that masks the identity of both the authors and reviewers, minimizing the potential for implicit biases. eNeuro is distinguished by a broader scope and balanced perspective achieved by publishing negative results, failure to replicate or replication studies. New research, computational neuroscience, theories and methods are also published.

About The Society for Neuroscience

The Society for Neuroscience is the world's largest organization of scientists and physicians devoted to understanding the brain and nervous system. The nonprofit organization, founded in 1969, now has nearly 37,000 members in more than 90 countries and over 130 chapters worldwide.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.